LBT

5.00%

1.9¢ lbt innovations limited

All great points and many of us agree with you. Where is the...

First 10 Last

Share
Profile

Follow
grayza1

829 Posts.

42

02/10/18

21:43

Post #: 35968552
Share

Originally posted by Callahan70 ↑

2016 AGM it was clearly stated

Discussions continue with global partner(s.) Increased interest post FDA Clearance. Timing of Letter Of Intent to be decided.

Signing of alliance/distribution agreement with global partners(s) for APAS

APAS Independence first Commercial sale by Global Alliance Partner

2017 AGM it was clearly stated

Signing of distribution agreement for APAS

2018 AGM is fast approaching

What will they say this year Signing of distribution agreement for APAS early 2019

I look at

Nanosonics with 299.2 million shares on issue a market cap of 1.1 billion and a shareprice of $ 3.60

Resapp Health with 659 Million shares on issue a market cap of 156 million and a share price of $ 0.22 doesn’t even have a product If we had a market cap of 156 million our share price would be $ 0.78

Then LBT with 201 million shares on issue and a market cap of 21 Million and a share price of $ 0.105

Something has to happen before AGM some objectives have to be met. I don’t want to hear about heavy lifting if you will, we need some results.

Some board members have been presiding over LBT for 12 years no less, unheard of these days and we have achieved very little, We need some more dynamic people on the board like Glenn Haifer and we need management to achieve some objectives.

We don’t even have a microbiologist on the board.

The current chair has been there since the original IPO at 0.20 and today we sit here at $ 0.105

If they had concentrated on getting the share price up, the options at 0.44 that expire in Nov and Dec might have been taken up which would of added 6 Million to the bottom line at a heathy price not these cap raises at 0.15

They can’t go to another AGM and present the next 12 months objectives when they haven’t achieved any from the year before.

CY18 Key Objectives as per 2017 AGM Presentation were

Extend APAS analysis modules Not done yet, That we know

Sales of APAS in Australia and NZ Only one sale

Sales of APAS in targeted European countries No sales achieved

Sales of APAS in USA No Sales achieved

Signing of distribution agreement Not done yet

FDA 510K supplement cleared for APAS Independence Not done yet

CE Marking for APAS No word

Market research for Woundvue Shelved

RAH 6 month review of Woundvue No word

These were all in the AGM presentation

12 months and none of the objectives have been met.

Its crunch time, time for results and it has to be before the AGM.

Current market cap lower than just the development cost of APAS.

It’s now or never. RESULTS must be forth coming

They have a wonderful machine, great AI, patented and proven and potential royalties of $60,000,000 on just 1500 machines. Never mind the profit share on the sales of the machine.

In my humble opinion.

60 million puts this young pup in the realms of a young cochlear.

The company has a future, but it has to start meeting objectives.

Expand

All great points and many of us agree with you.

Where is the push coming from though to turn our valid greivences from words into actions.

Where are the BIG shareholders that collectively control 50.1% of the issued capital calling for an EGM to dump the board?

LBT Price at posting: 10.5¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer’s drug could change the game

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

HotCopper Highlights: Your most watched stocks for Week 47, 2024

LPE

Sales growth pushes Lovisa's fortunes (and shares) upwards

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

SIG

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

There are more pages in this discussion • 74 more messages in this thread...

First 10 Last

Add LBT (ASX) to my watchlist

(20min delay)
Last 1.9¢		Change -0.001(5.00%)		Mkt cap ! $23.13M

Open	High	Low	Value	Volume
1.9¢	1.9¢	1.9¢	$4.463K	234.8K

Buyers (Bids)

No.	Vol.	Price($)
3	950618	1.8¢

Sellers (Offers)

Price($)	Vol.	No.
1.9¢	278267	1

View Market Depth

No.	Vol.	Price($)
1	2173	0.082
1	888	0.076
1	28682	0.070
1	5000	0.065
1	100000	0.062

Price($)	Vol.	No.
0.083	32748	1
0.084	58888	1
0.087	28000	1
0.089	50000	1
0.090	89000	2

Last trade - 13.53pm 22/11/2024 (20 minute delay)

LBT (ASX) Chart

All great points and many of us agree with you. Where is the...

This biotech stock raised $11M in a risk-off environment. Its Alzheimer’s drug could change the game

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

HotCopper Highlights: Your most watched stocks for Week 47, 2024

Sales growth pushes Lovisa's fortunes (and shares) upwards

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

All great points and many of us agree with you. Where is the...

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer’s drug could change the game

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

HotCopper Highlights: Your most watched stocks for Week 47, 2024

Sales growth pushes Lovisa's fortunes (and shares) upwards

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News